Lexicon amends Oxford loan: interest-only period to May 2027, maturity to March 2029

LEXICON PHARMACEUTICALS, INC.

Amortization date extended to May 1, 2027; maturity date extended to March 1, 2029.
Final payment percentage increased from prior amount to 7.00% of outstanding principal.
New financial covenant: minimum cash at 50% of outstanding Term Loans through June 30, 2026.
Minimum trailing 6-month net product revenue tied to sNDA approval of sotagliflozin in CKD by March 31, 2025.
Amendment fee paid; existing loan agreement continues in full force except as amended.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.